ALXO · Alx Oncology Holdings Inc
United States · RS rating 5 · As of 2026-10-14
| Price | 0.89 USD |
|---|---|
| 1-day change | -8.7% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 2 / 4 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 13 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -2.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +65.6% |
| Market cap (USD) | $214.0M |